Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This product is a **combination drug kit/preparation** containing povidone-iodine, lidocaine hydrochloride, and sodium chloride. In such combinations, **povidone-iodine** functions as a broad-spectrum topical antiseptic that releases free iodine and rapidly inactivates bacteria, fungi, viruses, and other microorganisms through oxidation and iodination of cellular components, while **lidocaine hydrochloride** is an amide local anesthetic that reversibly blocks voltage-gated sodium channels in neuronal membranes to inhibit initiation and conduction of nerve impulses, producing local anesthesia. **Sodium chloride** serves primarily as an isotonicity-adjusting excipient or diluent in the lidocaine-containing solution rather than as a therapeutic active ingredient. This type of combination is typically used in procedural or pre-procedural settings where local skin antisepsis and local anesthesia are both needed, often as part of a kit rather than a single novel molecular entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on povidone-iodine + lidocaine hydrochloride + sodium chloride.